Testing effectiveness (Phase 2)Study completedNCT02789254What this trial is testingFLYSYN in MRD Positive AMLWho this might be right forAcute Myeloid Leukemia Synimmune GmbH 31
Testing effectiveness (Phase 2)Ended earlyNCT01158885What this trial is testingClofarabine With Cytarabine for Patients With Minimal Residual Disease Positive LeukemiaWho this might be right forMinimal Residual DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute Therapeutic Advances in Childhood Leukemia Consortium 2
Testing effectiveness (Phase 2)UnknownNCT05362942What this trial is testingCombination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid LeukemiaWho this might be right forRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaMinimal Residual Disease Beijing 302 Hospital 52
Early research (Phase 1)Ended earlyNCT05001451What this trial is testingStudy of GDX012 in Patients With MRD Positive AMLWho this might be right forAcute Myeloid Leukemia GammaDelta Therapeutics Limited 3
Testing effectiveness (Phase 2)Ended earlyNCT03951961What this trial is testingMidostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell TransplantationWho this might be right forAcute Myeloid Leukemia, Adult University of Jena 1
Not applicableLooking for participantsNCT06066905What this trial is testingChidamide With AZA in MRD Positive AML After TransplantWho this might be right forAML, AdultMinimal Residual Disease Guangdong Provincial People's Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397What this trial is testingChemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT02520427What this trial is testingAMG 330 in Subjects With Myeloid MalignanciesWho this might be right forRelapsed/Refractory AMLMinimal Residual Disease Positive AMLMyelodysplastic Syndrome Amgen 95
Testing effectiveness (Phase 2)UnknownNCT04541277What this trial is testingCombined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive ChemotherapyWho this might be right forAcute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease Chinese PLA General Hospital 55
Not applicableLooking for participantsNCT06885476What this trial is testingInfusion of Alloreactive nk Cells for Mrd-positive Aml PatientsWho this might be right forAcute Myeloid LeukemiaMinimal Residual DiseaseNatural Killer Cell IRCCS Azienda Ospedaliero-Universitaria di Bologna 22
Large-scale testing (Phase 3)Study completedNCT00179829What this trial is testingWT1 for the Detection of Minimal Residual DiseaseWho this might be right forLeukemiaCancer Ann & Robert H Lurie Children's Hospital of Chicago 50
Testing effectiveness (Phase 2)WithdrawnNCT01677949What this trial is testingClofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Looking for participantsNCT03326921What this trial is testingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantWho this might be right forJuvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT02988466What this trial is testingReduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTWho this might be right forHematologic Malignancies Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)Looking for participantsNCT07256210What this trial is testingFeasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic T-cell LeukemiaMixed Phenotype Acute Leukemia Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Early research (Phase 1)Active Not RecruitingNCT03927261What this trial is testingPRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Precigen, Inc 88
Testing effectiveness (Phase 2)Study completedNCT03096782What this trial is testingUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia+19 more M.D. Anderson Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31
Not applicableLooking for participantsNCT07131059What this trial is testingMRD-positive AML Clinical StudyWho this might be right forAML, Adult Institute of Hematology & Blood Diseases Hospital, China 120